Weekly docetaxel with or without gemcitabine as second line chemotherapy in paclitaxel pretreated patients with metastatic breast cancer: A randomised phase II study conducted by the Hellenic Co-operative oncology group

被引：0
|
作者：
Zagouri, F. [1 ]
Bamias, A. [5 ]
Papakostas, P. [2 ]
Karadimou, A. [1 ]
Bournakis, E. [1 ]
Dimopoulos, M. [1 ]
Fountzilas, G. [3 ]
Papadimitriou, C. A. [4 ]
机构：
[1] Univ Athens, Sch Med, Dept Clin Therapeut, GR-11527 Athens, Greece
[2] Hippocrateio Hosp, Dept Med Oncol, Athens, Greece
[3] Aristotle Univ Thessaloniki, Sch Med, Dept Med Oncol, Thessaloniki, Greece
[4] Univ Athens, Sch Med, Alexandra Hosp, Dept Clin Therapeut, GR-11527 Athens, Greece
[5] Univ Athens, Sch Med, Dept Clin Therapeut 1, GR-11527 Athens, Greece
来源：
BREAST | 2009年 / 18卷
关键词：
D O I：
10.1016/S0960-9776(09)70210-3
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S66 / S66
页数：1
相关论文
共 50 条
  • [31] A phase II study of paclitaxel in platinum pretreated ovarian cancer. A Hellenic Cooperative Oncology Group Study
    Aravantinos, G
    Skarlos, DV
    Kosmidis, P
    Athanassiades, A
    Bafaloukos, D
    Giannakakis, T
    Karpathios, S
    Fountzilas, G
    EUROPEAN JOURNAL OF CANCER, 1997, 33 (01) : 160 - 163
  • [32] Gemcitabine plus paclitaxel and gemcitabine plus docetaxel in first- or second-line metastatic breast cancer: A phase II randomized trial
    Boccia, R. V.
    Vaughn, L.
    Zeigler, H.
    Wang, Y.
    Gill, J.
    Melemed, A.
    Shonukan, O.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [33] Weekly docetaxel and gemcitabine as first-line treatment for metastatic breast cancer:: Results of a multicenter phase II study
    Palmeri, S
    Vaglica, M
    Spada, S
    Filippelli, G
    Farris, A
    Palmeri, L
    Massidda, B
    Misino, A
    Ferraù, F
    Comella, G
    Leonardi, V
    Condemi, G
    Mangiameli, A
    De Cataldis, G
    Macaluso, MC
    Cajozzoo, M
    Iannitto, E
    Danova, M
    ONCOLOGY, 2005, 68 (4-6) : 438 - 445
  • [34] A phase II trial of docetaxel (Taxotere®) as second-line chemotherapy in patients with metastatic breast cancer
    Martina Baur
    Allan T. van Oosterom
    Véronique Diéras
    Michele Tubiana-Hulin
    R. Charles Coombes
    Thomas Hatschek
    Michael Murawsky
    May Klink-Alakl
    Marcus Hudec
    Christian Dittrich
    Journal of Cancer Research and Clinical Oncology, 2008, 134 : 125 - 135
  • [35] A phase II study of capecitabine and weekly docetaxel combination chemotherapy in patients with metastatic breast cancer.
    Puglisi, F
    Scalone, S
    Minisini, AM
    Mansutti, M
    Crivellari, D
    Buonadonna, A
    Zanetti, M
    Ermacora, P
    Piga, A
    Veronesi, A
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 78S - 78S
  • [36] A phase II trial of docetaxel (Taxotere®) as second-line chemotherapy in patients with metastatic breast cancer
    Baur, Martina
    van Oosterom, Allan T.
    Dieras, Veronique
    Tubiana-Hulin, Michele
    Coombes, R. Charles
    Hatschek, Thomas
    Murawsky, Michael
    Klink-Alakl, May
    Hudec, Marcus
    Dittrich, Christian
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2008, 134 (02) : 125 - 135
  • [37] Gemcitabine and Vinorelbine Combination Chemotherapy in Taxane-Pretreated Patients with Metastatic Breast Cancer: A Phase II Study of the Kinki Multidisciplinary Breast Oncology Group (KMBOG) 1015
    Yamamura, Jun
    Masuda, Norikazu
    Yamamoto, Daigo
    Tsuyuki, Shigeru
    Yamaguchi, Masahide
    Tanaka, Satoru
    Tsurutani, Junji
    Tokunaga, Shinya
    Yoshidome, Katsuhide
    Mizutani, Makiko
    Aono, Toyokazu
    Ooe, Asako
    Tanino, Hirokazu
    Matsunami, Nobuki
    Yasojima, Hiroyuki
    Nakayama, Takahiro
    Nishida, Yukihiro
    CHEMOTHERAPY, 2017, 62 (05) : 307 - 313
  • [38] A Phase II study of weekly nab-paclitaxel in combination with gemcitabine in patients with metastatic breast cancer.
    Zhao, Yannan
    Lv, Fangfang
    Chen, Shen
    Lu, Yunhua
    Cao, Enying
    Wang, Zhonghua
    Zhang, Jian
    Zhang, Sheng
    Cao, Jun
    Zheng, Chunlei
    Wang, Leiping
    Wang, Biyun
    Hu, Xichun
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [39] Phase II study of weekly docetaxel and capecitabine in patients with metastatic breast cancer
    Mrozek, Ewa
    Ramaswamy, Bhuvaneswari
    Young, Donn
    Rhoades, Chris A.
    Kendra, Kari
    Allen, Joan
    Moore, Tim
    Hauger, Marsha
    Watson, Holly
    Merriman, Nancy
    Nadella, Padma
    Villalona-Calero, Miguel
    Shapiro, Charles L.
    CLINICAL BREAST CANCER, 2006, 7 (02) : 141 - 145
  • [40] Gemcitabine and carboplatin combination as first-line treatment in elderly patients and those unfit for cisplatin-based chemotherapy with advanced bladder carcinoma: Phase II study of the Hellenic Co-Operative Oncology Group
    Linardou, H
    Aravantinos, G
    Efstathiou, E
    Kalofonos, C
    Anagnostopoulos, A
    Deliveliotis, C
    Bafaloukos, D
    Dimopoulos, MA
    Bamias, A
    UROLOGY, 2004, 64 (03) : 479 - 484
12345